Increasing efficacy of ADC products

Characterisaion of ADC's is a crtitical step for both research and development of efficacious and safe therapeutics
By: SMi Group
 
 
ADC-Summit
ADC-Summit
March 28, 2012 - PRLog -- SMi invites you to their inaugural ADC Summit held on the 23rd & 24th May 2012 in London. It will focus on the current ADC pipeline and present attendees with an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates.

The 2012 speaker line up, with key experts from all sectors of the industry will provide attendees with a unique insight into latest technological and scientific developments and will be the perfect platform for debate and problem-solving discussion.

Key benefits of attending:

•   Learn about and consider solutions to the issues within the current ADC pipeline from companies such as Seattle Genetics and Immunogen
•   Evaluate Genentech’s and GSK’s innovative strategies to ensure success in effective payload delivery  
•   Hear about bioanalytical developments from the FDA, Pfizer and Agensys
•   Consider novel linker strategy techniques to increase efficacy of ADC products
•   Discuss the most important factors in developing a successful antibody-drug conjugate in an industry led panel discussion
•   Understand from case studies the key challenges in ADC design
•   Network with key industry professionals  

For more information visit http://www.smi-online.co.uk/adcsummit46.asp
Alternatively contact Fateja Begum on fbegum@smi-online.co.uk or tel. +44 0207 827 6184
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Adc, Drug, Conjugate, Cancerous, Cells, Tumour, Antigen, Tumor
Industry:Pharmaceutical
Location:England
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share